STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM
June 26, 2024 10:00 ET
|
Monteverde & Associates PC
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022...
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM
June 21, 2024 11:02 ET
|
Monteverde & Associates PC
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the...
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – SQSP, RPHM, SBOW, NX
May 29, 2024 13:29 ET
|
Monteverde & Associates PC
NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the...
Kuehn Law Encourages SQSP, HRT, RPHM, and ALE Investors to Contact Law Firm
May 14, 2024 15:52 ET
|
KUEHN LAW, PLLC
Kuehn Law Encourages SQSP, HRT, RPHM, and ALE Investors to Contact Law Firm
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
May 13, 2024 07:35 ET
|
Reneo Pharmaceuticals, Inc.; OnKure, Inc
Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing OnKure’s portfolio of novel precision medicines in oncology Combined company is expected to have...
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
May 07, 2024 07:35 ET
|
Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results